Literature DB >> 34089409

Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial.

Nathan S McClure1,2, Mike Paulden1, Arto Ohinmaa1,2, Jeffrey A Johnson3,4.   

Abstract

BACKGROUND: We propose a modified quality-adjusted life year (QALY) calculation that aims to be consistent with guidance for interpreting change in patient-reported outcomes. This calculation incorporates the minimally important difference (MID) in generic preference-based health-related quality of life (HRQL) change scores to reflect what might be considered meaningful HRQL improvement/deterioration. In doing so, we review common issues in QALY calculations such as adjustment for baseline scores and standardizing for between-group differences.
METHODS: Using EQ-5D-5L outcome data from the Alberta TEAMCare-Primary Care Network trial in the management of depression for patients with type 2 diabetes (n = 98), this study compared results from different QALY calculation methods to investigate the impact of (i) adjusting for baseline HRQL score, (ii) standardizing between-group differences at baseline, and (iii) adjusting for 'meaningful' HRQL changes. The following QALY calculation methods are examined: area under curve (QALY-AUC), change from baseline (QALY-CFB), regression modelling (QALY-R), and incorporating an MID for HRQL changes from baseline (QALY-MID).
RESULTS: The incremental QALY-AUC estimate favoured the Collaborative Care group (0.031) while the incremental QALY-CFB (-0.028) estimate favoured Enhanced Care. Adjusting for meaningful HRQL changes resulted in a crude incremental QALY-MID of -0.023; however, after adjusting for between-group differences at baseline, QALY-R and adjusted incremental QALY-MID estimates were -0.007 and -0.001, respectively. In addition, recursive regression analyses showed that very low baseline HRQL scores impact incremental QALY estimates.
CONCLUSIONS: Uncertainty in incremental QALY estimates reflects uncertainty in the value of small within-individual change as well as the impact of small differences between groups at baseline. Applying a responder-definition approach yielded crude and adjusted QALY-MID estimates that were more in favour of Collaborative Care than QALY-CFB and QALY-R estimates, respectively, suggesting that ambiguous small changes in HRQL scores have the potential to influence QALY outcomes used in economic or non-economic applications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Depression; Health-related quality of life; Minimally important difference; Quality-adjusted life year; Type 2 diabetes

Mesh:

Year:  2021        PMID: 34089409     DOI: 10.1007/s10198-021-01324-x

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  24 in total

Review 1.  Are quality of life measures patient centred?

Authors:  A J Carr; I J Higginson
Journal:  BMJ       Date:  2001-06-02

2.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

Authors:  Andrea Manca; Neil Hawkins; Mark J Sculpher
Journal:  Health Econ       Date:  2005-05       Impact factor: 3.046

3.  The use of QALYs in clinical and patient decision-making: issues and prospects.

Authors:  Paul Kind; Jennifer Elston Lafata; Karl Matuszewski; Dennis Raisch
Journal:  Value Health       Date:  2009-03       Impact factor: 5.725

4.  Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare.

Authors:  Elizabeth F Franklin; Helen M Nichols; Ellyn Charap; Joanne S Buzaglo; Alexandra K Zaleta; Linda House
Journal:  Value Health       Date:  2018-12-29       Impact factor: 5.725

5.  Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores.

Authors:  Cheryl D Coon; Karon F Cook
Journal:  Qual Life Res       Date:  2017-06-15       Impact factor: 4.147

Review 6.  Minimal important difference to infer changes in health-related quality of life-a systematic review.

Authors:  Ravishankar Jayadevappa; Ratna Cook; Sumedha Chhatre
Journal:  J Clin Epidemiol       Date:  2017-07-01       Impact factor: 6.437

7.  Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study.

Authors:  Kristen Pickles; Emily Lancsar; Janelle Seymour; David Parkin; Cam Donaldson; Stacy M Carter
Journal:  Soc Sci Med       Date:  2019-09-19       Impact factor: 4.634

8.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

9.  The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.

Authors:  Sara Ahmed; Richard A Berzon; Dennis A Revicki; William R Lenderking; Carol M Moinpour; Ethan Basch; Bryce B Reeve; Albert W Wu
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

10.  Quantifying life: Understanding the history of Quality-Adjusted Life-Years (QALYs).

Authors:  Eleanor MacKillop; Sally Sheard
Journal:  Soc Sci Med       Date:  2018-07-03       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.